• / Free eNewsletters & Magazine
  • / My Account
Home>Search Results

Related Content

  1. Videos
  2. Articles
  1. MLPs: High-Quality Income Generators

    Tax advantages and economic moats allow master limited partnerships to offer investors much more than just high yields, says Morningstar's Paul Larson.

  2. No Shortage of Suitors for Genzyme

    Facing dwindling drug pipelines, plenty of big pharma firms may end up jumping into the bidding for Genzyme, according to Morningstar's Karen Andersen.

  3. How Will M&A Affect Pharma Balance Sheets?

    Even if a potential Sanofi/Genzyme deal foretells a wave of consolidation, investors shouldn't worry about big pharma credit quality, says Morningstar's Julie Stralow.

  4. Personalized Medicine is the Future

    Gen-Probe's CFO Herm Rosenman says the firm has plenty of catalysts that should drive growth for the next several years.

  1. Citi Said to Give CCA Managers 75% Stake in Funds for Free

    Among Vikram Pandit's last jobs as Citigroup Inc.'s chief executive officer was to decide the fate of the bank's hedge-fund unit, which employs some of his oldest colleagues. He agreed to give them most of it for free.

  2. Diversification into International Fixed Income: Tempering the Influence of U.S.Deficits, Cliffs, and Ceilings in a Portfolio

     

  3. No C-E change as CFP Board scraps controversial plan

    Proposal would have hiked continuing-education requirements for registrants; no shortage of comments.

  4. LPL Taps Ex-Dell CIO for Top Tech Post

    Victor Fetter will move from Austin to Charlotte, N.C., to head the independent broker-dealer's growing IT squad.

1
ShareEmail
Print
Text Size
Comment
blog comments powered by Disqus
Our Products
Tools
Resources
Services
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.